These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19323275)

  • 1. Modulation of anticancer drug-induced P-glycoprotein expression by naringin.
    Ali MM; Agha FG; El-Sammad NM; Hassan SK
    Z Naturforsch C J Biosci; 2009; 64(1-2):109-16. PubMed ID: 19323275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
    Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
    Choudhuri SK; Chatterjee A
    Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.
    Fardel O; Lecureur V; Daval S; Corlu A; Guillouzo A
    Eur J Biochem; 1997 May; 246(1):186-92. PubMed ID: 9210482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A; Daly AK; Atherton K; Campbell FC
    Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
    Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
    Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic.
    Liu J; Chen H; Miller DS; Saavedra JE; Keefer LK; Johnson DR; Klaassen CD; Waalkes MP
    Mol Pharmacol; 2001 Aug; 60(2):302-9. PubMed ID: 11455017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine.
    Ruiz-Gómez MJ; Souviron A; Martínez-Morillo M; Gil L
    J Physiol Biochem; 2000 Dec; 56(4):307-12. PubMed ID: 11321524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment.
    Fardel O; Lecureur V; Corlu A; Guillouzo A
    Biochem Pharmacol; 1996 Jun; 51(11):1427-36. PubMed ID: 8630083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2.
    Hong L; Piao Y; Han Y; Wang J; Zhang X; Du Y; Cao S; Qiao T; Chen Z; Fan D
    Mol Cancer Ther; 2005 Dec; 4(12):1936-42. PubMed ID: 16373708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.
    Krishna R; Mayer LD
    Eur J Pharm Sci; 2000 Oct; 11(4):265-83. PubMed ID: 11033070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.